|
Many of the world's most renowned, respected and active pediatric cancer researchers work at Children's Hospital Boston and Dana-Farber Cancer Institute. By working to understand the scientific roots of pediatric cancer, these experts have pioneered childhood cancer treatment advancements, beginning with the first successful remission of childhood leukemia by Sidney Farber, MD.
Together, Children's and Dana-Farber researchers are designing treatments that promise to increase survival rates for children in the most advanced stages of illness. The experts oversee the most Phase I clinical trials in New England, giving your child access to the most advanced treatment options possible.
Dana-Farber/Children's Hospital Cancer Care researchers assume active roles in the following childhood cancer research groups:
|
Holcombe Grier, M.D., Associate Chief of Pediatric Clinical Oncology, was recently appointed President of the American Society of Pediatric Hematology-Oncology, which represents pediatric hematologists and oncologists throughout the United States.
